Combined use of SGLT2 inhibitors and GLP-1 receptor agonists also significantly increased the risk for falls. (HealthDay News) — Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an ...

Despite promising adherence and persistence data, tirzepatide dose escalation was slower in the real-world than clinical trials in patients with obesity without T2D. Tirzepatide dose escalation is ...

Proportion of adult managed care organizations with availability varied from 24 to 100 percent for SGLT2 inhibitors, 0 to 99 percent for GLP-1 receptor agonists. (HealthDay News) — Many Medicaid ...

Outbreak mainly affected members of communities with low measles vaccination coverage in New Mexico, Oklahoma, and Texas. (HealthDay News) — Eight hundred cases of measles were reported in the ...

Despite improvements in care delivery and provider responsiveness, these data show that substantial barriers to fatigue communication endure. Barriers to discussing cancer-related fatigue with ...

A trial of a permanent prostatic urethral stent for treatment of BPH demonstrated early success. A novel prostatic urethral stent can reduce lower urinary tract symptoms (LUTS) in men with benign ...

Measles may reestablish endemicity, with an estimated 851,300 cases over 25 years at current vaccination rates. (HealthDay News) — Declining childhood vaccination rates may increase outbreaks of ...